Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 7
2005 1
2007 9
2008 5
2009 4
2010 3
2011 7
2012 1
2013 3
2014 5
2015 9
2016 8
2017 3
2018 4
2019 3
2020 9
2021 2
2022 7
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative.
Dick AD, Rosenbaum JT, Al-Dhibi HA, Belfort R Jr, Brézin AP, Chee SP, Davis JL, Ramanan AV, Sonoda KH, Carreño E, Nascimento H, Salah S, Salek S, Siak J, Steeples L; Fundamentals of Care for Uveitis International Consensus Group. Dick AD, et al. Ophthalmology. 2018 May;125(5):757-773. doi: 10.1016/j.ophtha.2017.11.017. Epub 2018 Jan 6. Ophthalmology. 2018. PMID: 29310963 Free article.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Ocular Paraneoplastic Syndromes.
Przeździecka-Dołyk J, Brzecka A, Ejma M, Misiuk-Hojło M, Torres Solis LF, Solís Herrera A, Somasundaram SG, Kirkland CE, Aliev G. Przeździecka-Dołyk J, et al. Among authors: misiuk hojlo m. Biomedicines. 2020 Nov 10;8(11):490. doi: 10.3390/biomedicines8110490. Biomedicines. 2020. PMID: 33182708 Free PMC article. Review.
Advancements in Ocular Regenerative Therapies.
Tomczak W, Winkler-Lach W, Tomczyk-Socha M, Misiuk-Hojło M. Tomczak W, et al. Among authors: misiuk hojlo m. Biology (Basel). 2023 May 19;12(5):737. doi: 10.3390/biology12050737. Biology (Basel). 2023. PMID: 37237549 Free PMC article. Review.
Ocular manifestations of pulmonary hypertension.
Lewczuk N, Zdebik A, Bogusławska J, Turno-Kręcicka A, Misiuk-Hojło M. Lewczuk N, et al. Among authors: misiuk hojlo m. Surv Ophthalmol. 2019 Sep-Oct;64(5):694-699. doi: 10.1016/j.survophthal.2019.02.009. Epub 2019 Mar 6. Surv Ophthalmol. 2019. PMID: 30849428 Review.
Immunopathogenic Background of Pars Planitis.
Przeździecka-Dołyk J, Węgrzyn A, Turno-Kręcicka A, Misiuk-Hojło M. Przeździecka-Dołyk J, et al. Among authors: misiuk hojlo m. Arch Immunol Ther Exp (Warsz). 2016 Apr;64(2):127-37. doi: 10.1007/s00005-015-0361-y. Epub 2015 Oct 5. Arch Immunol Ther Exp (Warsz). 2016. PMID: 26438050 Free PMC article. Review.
Mycotic Infections of the Eye.
Słowik M, Biernat MM, Urbaniak-Kujda D, Kapelko-Słowik K, Misiuk-Hojło M. Słowik M, et al. Among authors: misiuk hojlo m. Adv Clin Exp Med. 2015 Nov-Dec;24(6):1113-7. doi: 10.17219/acem/50572. Adv Clin Exp Med. 2015. PMID: 26771986 Free article. Review.
The Links between Parkinson's Disease and Cancer.
Ejma M, Madetko N, Brzecka A, Guranski K, Alster P, Misiuk-Hojło M, Somasundaram SG, Kirkland CE, Aliev G. Ejma M, et al. Among authors: misiuk hojlo m. Biomedicines. 2020 Oct 14;8(10):416. doi: 10.3390/biomedicines8100416. Biomedicines. 2020. PMID: 33066407 Free PMC article. Review.
97 results